BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 21947363)

  • 1. Long lasting remission by rituximab in a patient with primary cold agglutinin autoimmune haemolytic anaemia.
    Glaser M; Glaser A; Skalicky M
    Wien Klin Wochenschr; 2011 Nov; 123(21-22):680-3. PubMed ID: 21947363
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Cold agglutinin disease -  no response to glucocorticoids and rituximab, what treatment is best for the 3rd line of therapy? Case report and review of the literature].
    Adam Z; Pejchalová A; Chlupová G; Ríhová L; Pour L; Krejčí M; Cervinek L; Král Z; Mayer J
    Vnitr Lek; 2013 Sep; 59(9):828-40. PubMed ID: 24073955
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A case of autoimmune haemolytic anaemia achieving complete response with rituximab.
    Dev M; Mushtaq N; Faisal A
    J Pak Med Assoc; 2014 Jun; 64(6):700-2. PubMed ID: 25252495
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Delayed response to rituximab of cold agglutinin haemolytic disease].
    Calvo-Villas JM; Cuesta Tovar J; Carreter de Granda E; Sicilia Guillén F
    An Med Interna; 2006 May; 23(5):224-8. PubMed ID: 16817700
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of rituximab-bendamustine in cold agglutinin haemolytic anaemia refractory to previous chemo-immunotherapy: a case report.
    Gueli A; Gottardi D; Hu H; Ricca I; De Crescenzo A; Tarella C
    Blood Transfus; 2013 Apr; 11(2):311-4. PubMed ID: 23399352
    [No Abstract]   [Full Text] [Related]  

  • 6. Severe refractory autoimmune hemolytic anemia with five-year complete hematologic response to third course of treatment with rituximab: a case report.
    Abadie K; Hege KM
    J Med Case Rep; 2014 Jun; 8():175. PubMed ID: 24889270
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-lasting remission induced by rituximab in two cases of refractory autoimmune haemolytic anaemia due to cold agglutinins.
    Palombi M; Niscola P; Trawinska MM; Scaramucci L; Giovannini M; Perrotti A; de Fabritiis P
    Blood Transfus; 2009 Jul; 7(3):235-6. PubMed ID: 19657487
    [No Abstract]   [Full Text] [Related]  

  • 8. Successful treatment of cold agglutinin disease with anti-CD20 antibody (rituximab) in a patient with systemic lupus erythematosus.
    Kotani T; Takeuchi T; Kawasaki Y; Hirano S; Tabushi Y; Kagitani M; Makino S; Hanafusa T
    Lupus; 2006; 15(10):683-5. PubMed ID: 17120596
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adult Evans syndrome: complete hematologic recovery with steroids and rituximab: a case report.
    Santiago-Ríos KJ; Reyes O; Cruz A; Rodríguez-Pabón N; Cáceres W
    Bol Asoc Med P R; 2010; 102(2):33-6. PubMed ID: 20939201
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Successful treatment with rituximab in a patient with refractory mixed-type autoimmune hemolytic anemia].
    Ono K; Sato T; Iyama S; Tatekoshi A; Hashimoto A; Kamihara Y; Horiguchi H; Kikuchi S; Takada K; Hayashi T; Miyanishi K; Sato Y; Takimoto R; Kobune M; Kato J
    Rinsho Ketsueki; 2013 Nov; 54(11):2053-5. PubMed ID: 24305538
    [TBL] [Abstract][Full Text] [Related]  

  • 11. B-cell depletion induces prolonged remission in patients with giant cell hepatitis and autoimmune hemolytic anemia.
    Matarazzo L; Di Chio T; Nastasio S; Tommasini A; Ventura A; Maggiore G
    Clin Res Hepatol Gastroenterol; 2020 Feb; 44(1):66-72. PubMed ID: 31076361
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A multi-centre retrospective study of rituximab use in the treatment of relapsed or resistant warm autoimmune haemolytic anaemia.
    Maung SW; Leahy M; O'Leary HM; Khan I; Cahill MR; Gilligan O; Murphy P; McPherson S; Jackson F; Ryan M; Hennessy B; McHugh J; Goodyer M; Bacon L; O'Gorman P; Nee A; O'Dwyer M; Enright H; Saunders J; O'Keeffe D
    Br J Haematol; 2013 Oct; 163(1):118-22. PubMed ID: 23909468
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rituximab in the treatment of autoimmune haemolytic anaemia.
    Rodrigo C; Rajapakse S; Gooneratne L
    Br J Clin Pharmacol; 2015 May; 79(5):709-19. PubMed ID: 25139610
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of refractory fludarabine induced autoimmune haemolytic with the anti-CD20 monoclonal antibody rituximab.
    Swords R; Nolan A; Fay M; Quinn J; O'Donnell R; Murphy PT
    Clin Lab Haematol; 2006 Feb; 28(1):57-9. PubMed ID: 16430461
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Beneficial effect of rituximab in combination with oral cyclophosphamide in primary chronic cold agglutinin disease.
    Vassou A; Alymara V; Chaidos A; Bourantas KL
    Int J Hematol; 2005 Jun; 81(5):421-3. PubMed ID: 16158824
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rituximab for treatment of autoimmune hemolytic anemia.
    Kuzmanovic M; Jurisic V
    Indian Pediatr; 2012 Aug; 49(8):672-4. PubMed ID: 22962244
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Autoimmune haemolytic anaemia: a review and report of four cases].
    Nyilas R; Székely B; Váróczy L; Simon Z; Árokszállási A; Illés Á; Gergely L
    Orv Hetil; 2015 Mar; 156(11):449-56. PubMed ID: 25749539
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of childhood autoimmune haemolytic anaemia with rituximab.
    Quartier P; Brethon B; Philippet P; Landman-Parker J; Le Deist F; Fischer A
    Lancet; 2001 Nov; 358(9292):1511-3. PubMed ID: 11705566
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Success of anti-CD20 monoclonal antibody treatment for severe autoimmune hemolytic anemia caused by warm-reactive immunoglobulin A, immunoglobulin G, and immunoglobulin M autoantibodies in a child: a case report.
    Ajmi H; Mabrouk S; Hassayoun S; Regaieg H; Tfifha M; Jalel C; Skouri H; Zouari N; Abroug S
    J Med Case Rep; 2017 Nov; 11(1):321. PubMed ID: 29132419
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Efficacity of rituximab in hemolytic anemia with cold autoantibodies case].
    Sekkach Y; Hammi S; Elqatni M; Fatihi J; Elomri N; Mekouar F; Badaoui M; Jira M; Smaali J; El Khattabi A; Amezyane T; Abouzahir A; Ghafir D
    Ann Pharm Fr; 2011 Jul; 69(4):205-8. PubMed ID: 21840439
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.